Followers | 645 |
Posts | 10,613 |
Boards Moderated | 2 |
Alias Born | 03/07/2015 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Got 4M. Great reward/risk ratio.
MSTO is back with tier change from expert to Pink (limited for few more days. Multiple filings to get back to trading. No brainer to collect some NOW IMO. Masterbeat Corporation owns 70% of its subsidiary SBQ, LLC. The remaining 30% is owned by its current
Chief Executive Officer.
Outstanding Shares 1,265,434,915 04/25/2023
Restricted 32,345,325 04/25/2023
Unrestricted 1,233,089,590 04/25 2023
https://www.otcmarkets.com/otcapi/company/financial-report/365752/content
CEO via tweet: " watch for announcents of progress being made at both Navarre and Baird Rd Properties"
website: https://www.masterbeatcorp.com/
Twitter: https://twitter.com/masterbeatcorp
Subsidiaries:
SBQ Holdings, LLC https://twitter.com/LlcSbq
JTEC Automotive, Inc. https://twitter.com/AutomotiveJtec
Financing through offering at 0.001 (2x over current pps)
((https://www.otcmarkets.com/filing/conv_pdf?id=16474224&guid=tFm-ka3VoTiqJth
MSTO is back with tier change from expert to Pink (limited for few more days. Multiple filings to get back to trading. No brainer to collect some NOW IMO. Masterbeat Corporation owns 70% of its subsidiary SBQ, LLC. The remaining 30% is owned by its current
Chief Executive Officer.
Outstanding Shares 1,265,434,915 04/25/2023
Restricted 32,345,325 04/25/2023
Unrestricted 1,233,089,590 04/25 2023
https://www.otcmarkets.com/otcapi/company/financial-report/365752/content
CEO via tweet: " watch for announcents of progress being made at both Navarre and Baird Rd Properties"
website: https://www.masterbeatcorp.com/
Twitter: https://twitter.com/masterbeatcorp
Subsidiaries:
SBQ Holdings, LLC https://twitter.com/LlcSbq
JTEC Automotive, Inc. https://twitter.com/AutomotiveJtec
Financing through offering at 0.001 (2x over current pps)
((https://www.otcmarkets.com/filing/conv_pdf?id=16474224&guid=tFm-ka3VoTiqJth
MSTO back from the dead: No brainer to collect some NOW IMO. Masterbeat Corporation owns 70% of its subsidiary SBQ, LLC. The remaining 30% is owned by its current
Chief Executive Officer.
Outstanding Shares 1,265,434,915 04/25/2023
Restricted 32,345,325 04/25/2023
Unrestricted 1,233,089,590 04/25 2023
tier change from expert to Pink (limited for few more days. Multiple filings to get back to trading.
https://www.otcmarkets.com/otcapi/company/financial-report/365752/content
CEO via tweet: " watch for announcents of progress being made at both Navarre and Baird Rd Properties"
website: https://www.masterbeatcorp.com/
Twitter: https://twitter.com/masterbeatcorp
Subsidiaries:
SBQ Holdings, LLC https://twitter.com/LlcSbq
JTEC Automotive, Inc. https://twitter.com/AutomotiveJtec
Financing through offering at 0.001 (2x over current pps)
((https://www.otcmarkets.com/filing/conv_pdf?id=16474224&guid=tFm-ka3VoTiqJth
MSTO back from the dead: No brainer to collect some NOW IMO. Masterbeat Corporation owns 70% of its subsidiary SBQ, LLC. The remaining 30% is owned by its current
Chief Executive Officer.
Outstanding Shares 1,265,434,915 04/25/2023
Restricted 32,345,325 04/25/2023
Unrestricted 1,233,089,590 04/25 2023
tier change from expert to Pink (limited for few more days. Multiple filings to get back to trading.
https://www.otcmarkets.com/otcapi/company/financial-report/365752/content
CEO via tweet: " watch for announcents of progress being made at both Navarre and Baird Rd Properties"
website: https://www.masterbeatcorp.com/
Twitter: https://twitter.com/masterbeatcorp
Subsidiaries:
SBQ Holdings, LLC https://twitter.com/LlcSbq
JTEC Automotive, Inc. https://twitter.com/AutomotiveJtec
Financing through offering at 0.001 (2x over current pps)
((https://www.otcmarkets.com/filing/conv_pdf?id=16474224&guid=tFm-ka3VoTiqJth
MSTO bottom in: No brainer to collect some NOW IMO. Masterbeat Corporation owns 70% of its subsidiary SBQ, LLC. The remaining 30% is owned by its current
Chief Executive Officer.
Outstanding Shares 1,265,434,915 04/25/2023
Restricted 32,345,325 04/25/2023
Unrestricted 1,233,089,590 04/25 2023
tier change from expert to Pink (limited for few more days. Multiple filings to get back to trading.
https://www.otcmarkets.com/otcapi/company/financial-report/365752/content
CEO via tweet: " watch for announcents of progress being made at both Navarre and Baird Rd Properties"
website: https://www.masterbeatcorp.com/
Twitter: https://twitter.com/masterbeatcorp
Subsidiaries:
SBQ Holdings, LLC https://twitter.com/LlcSbq
JTEC Automotive, Inc. https://twitter.com/AutomotiveJtec
Financing through offering at 0.001 (2x over current pps)
((https://www.otcmarkets.com/filing/conv_pdf?id=16474224&guid=tFm-ka3VoTiqJth
MSTO bottom in: No brainer to collect some NOW IMO. Masterbeat Corporation owns 70% of its subsidiary SBQ, LLC. The remaining 30% is owned by its current
Chief Executive Officer.
Outstanding Shares 1,265,434,915 04/25/2023
Restricted 32,345,325 04/25/2023
Unrestricted 1,233,089,590 04/25 2023
tier change from expert to Pink (limited for few more days. Multiple filings to get back to trading.
https://www.otcmarkets.com/otcapi/company/financial-report/365752/content
CEO via tweet: " watch for announcents of progress being made at both Navarre and Baird Rd Properties"
website: https://www.masterbeatcorp.com/
Twitter: https://twitter.com/masterbeatcorp
Subsidiaries:
SBQ Holdings, LLC https://twitter.com/LlcSbq
JTEC Automotive, Inc. https://twitter.com/AutomotiveJtec
Financing through offering at 0.001 (2x over current pps)
((https://www.otcmarkets.com/filing/conv_pdf?id=16474224&guid=tFm-ka3VoTiqJth
MSTO: Masterbeat Corporation owns 70% of its subsidiary SBQ, LLC. The remaining 30% is owned by its current
Chief Executive Officer.
Outstanding Shares 1,265,434,915 04/25/2023
Restricted 32,345,325 04/25/2023
Unrestricted 1,233,089,590 04/25 2023
tier change from expert to Pink (limited for few more days. Multiple filings to get back to trading. No brainer to collect some NOW IMO.
https://www.otcmarkets.com/otcapi/company/financial-report/365752/content
CEO via tweet: " watch for announcents of progress being made at both Navarre and Baird Rd Properties"
website: https://www.masterbeatcorp.com/
Twitter: https://twitter.com/masterbeatcorp
Subsidiaries:
SBQ Holdings, LLC https://twitter.com/LlcSbq
JTEC Automotive, Inc. https://twitter.com/AutomotiveJtec
Financing through offering at 0.001 (2x over current pps)
((https://www.otcmarkets.com/filing/conv_pdf?id=16474224&guid=tFm-ka3VoTiqJth
MSTO: Masterbeat Corporation owns 70% of its subsidiary SBQ, LLC. The remaining 30% is owned by its current
Chief Executive Officer.
Outstanding Shares 1,265,434,915 04/25/2023
Restricted 32,345,325 04/25/2023
Unrestricted 1,233,089,590 04/25 2023
tier change from expert to Pink (limited for few more days. Multiple filings to get back to trading. No brainer to collect some NOW IMO.
https://www.otcmarkets.com/otcapi/company/financial-report/365752/content
CEO via tweet: " watch for announcents of progress being made at both Navarre and Baird Rd Properties"
website: https://www.masterbeatcorp.com/
Twitter: https://twitter.com/masterbeatcorp
Subsidiaries:
SBQ Holdings, LLC https://twitter.com/LlcSbq
JTEC Automotive, Inc. https://twitter.com/AutomotiveJtec
Financing through offering at 0.001 (2x over current pps)
((https://www.otcmarkets.com/filing/conv_pdf?id=16474224&guid=tFm-ka3VoTiqJth
MSTO:
Outstanding Shares 1,265,434,915 04/25/2023
Restricted 32,345,325 04/25/2023
Unrestricted 1,233,089,590 04/25 2023
tier change from expert to Pink (limited for few more days. Multiple filings to get back to trading. No brainer to collect some NOW IMO.
https://www.otcmarkets.com/otcapi/company/financial-report/365752/content
CEO via tweet: " watch for announcents of progress being made at both Navarre and Baird Rd Properties"
website: https://www.masterbeatcorp.com/
Twitter: https://twitter.com/masterbeatcorp
Subsidiaries:
SBQ Holdings, LLC https://twitter.com/LlcSbq
JTEC Automotive, Inc. https://twitter.com/AutomotiveJtec
Masterbeat Corporation owns 70% of its subsidiary SBQ, LLC. The remaining 30% is owned by its current
Chief Executive Officer.
Financing through offering at 0.001 (2x over current pps)
((https://www.otcmarkets.com/filing/conv_pdf?id=16474224&guid=tFm-ka3VoTiqJth
MSTO:
Outstanding Shares 1,265,434,915 04/25/2023
Restricted 32,345,325 04/25/2023
Unrestricted 1,233,089,590 04/25 2023
tier change from expert to Pink (limited for few more days. Multiple filings to get back to trading. No brainer to collect some NOW IMO.
https://www.otcmarkets.com/otcapi/company/financial-report/365752/content
CEO via tweet: " watch for announcents of progress being made at both Navarre and Baird Rd Properties"
website: https://www.masterbeatcorp.com/
Twitter: https://twitter.com/masterbeatcorp
Subsidiaries:
SBQ Holdings, LLC https://twitter.com/LlcSbq
JTEC Automotive, Inc. https://twitter.com/AutomotiveJtec
Masterbeat Corporation owns 70% of its subsidiary SBQ, LLC. The remaining 30% is owned by its current
Chief Executive Officer.
Financing through offering at 0.001 (2x over current pps)
((https://www.otcmarkets.com/filing/conv_pdf?id=16474224&guid=tFm-ka3VoTiqJth
MSTO: tier change from expert to Pink (limited for few more days. Multiple filings to get back to trading. No brainer to collect some NOW IMO.
Outstanding Shares 1,265,434,915 04/25/2023
Restricted 32,345,325 04/25/2023
Unrestricted 1,233,089,590 04/25 2023
https://www.otcmarkets.com/otcapi/company/financial-report/365752/content
CEO via tweet: " watch for announcents of progress being made at both Navarre and Baird Rd Properties"
website: https://www.masterbeatcorp.com/
Twitter: https://twitter.com/masterbeatcorp
Subsidiaries:
SBQ Holdings, LLC https://twitter.com/LlcSbq
JTEC Automotive, Inc. https://twitter.com/AutomotiveJtec
Masterbeat Corporation owns 70% of its subsidiary SBQ, LLC. The remaining 30% is owned by its current
Chief Executive Officer.
Financing through offering at 0.001 (2x over current pps)
((https://www.otcmarkets.com/filing/conv_pdf?id=16474224&guid=tFm-ka3VoTiqJth
MSTO: tier change from expert to Pink (limited for few more days. Multiple filings to get back to trading. No brainer to collect some NOW IMO.
Outstanding Shares 1,265,434,915 04/25/2023
Restricted 32,345,325 04/25/2023
Unrestricted 1,233,089,590 04/25 2023
https://www.otcmarkets.com/otcapi/company/financial-report/365752/content
CEO via tweet: " watch for announcents of progress being made at both Navarre and Baird Rd Properties"
website: https://www.masterbeatcorp.com/
Twitter: https://twitter.com/masterbeatcorp
Subsidiaries:
SBQ Holdings, LLC https://twitter.com/LlcSbq
JTEC Automotive, Inc. https://twitter.com/AutomotiveJtec
Masterbeat Corporation owns 70% of its subsidiary SBQ, LLC. The remaining 30% is owned by its current
Chief Executive Officer.
Financing through offering at 0.001 (2x over current pps)
((https://www.otcmarkets.com/filing/conv_pdf?id=16474224&guid=tFm-ka3VoTiqJth
Financial report out. SS same. No debt.
https://www.otcmarkets.com/otcapi/company/financial-report/367220/content
I spoke to the CEO by phone on monday just to share knowledge about OTC trading intricacies and the use of social media to counteract some of the "gambling & flipping action". He said that the good thing now is that folks come in who soon can handle public relations and twitter etc. (referring to the pushmonkey team). He seems genuine enough for me not to shed my shares (6M and adding) on the next little spike.
Absolutely...with patience this is going to spike once again like crazy sometime this year
HRAL merger w. established AI management system; tiny-float w. preserved SS; little debt
HearAtLast Holdings, Inc OTC: HRAL Signs Agreement to Purchase GetPushMonkey.com Press Release | 04/21/2023
https://www.otcmarkets.com/stock/HRAL/news/HearAtLast-Holdings-Inc-OTC-HRAL-Signs-Agreement-to-Purchase-GetPushMonkeycom?id=397488
GEORGETOWN, ON / ACCESSWIRE / April 21, 2023 / HearAtLast Holdings, Inc, (OTC:HRAL) announces the signing of agreement to purchase GetPushMonkey.com (See https://getpushmonkey.com/) a business development contact management system which utilizes cutting-edge AI data intelligence "web push" that provides businesses with the ability to turn real-time data into actionable insights and personalized customer engagement to generate increased profits.
Web push notifications offer businesses a powerful tool for engaging with their audience and driving conversions, as they can be delivered in real-time and are highly targeted." Overall, I believe, the web push notification market is expected to continue growing in the coming years, as more businesses recognize the value of this powerful marketing channel and invest in innovative solutions to reach and engage with their audience".
"I am excited about the opportunities this merger will bring. We believe that this merger will enable us to expand and better serve our clients and provide them with even greater value". Says CEO Aashish Khandelwal of GetPushMonkey.com. Aashish Khandelwal will be continuing with HRAL following the purchase, heading up the marketing efforts.
Pete Wanner, the CEO of HearAtLast Holdings, Inc, OTC: HRAL states, " We hope to use our network of existing contacts, to drive significant traffic to PushMonkey. We see the partnership with PushMonkey as being a dramatic step forward for both companies"
Market Cap 383,060 04/23/2023
Outstanding Shares 294,661,157 04/23/2023
Restricted 37,574,169 04/23/2023
Unrestricted 257,086,988 04/23/2023
Push Monkey's annual revenue: $1,457,000 Website: https://getpushmonkey.com/
Soc. Media etc:
https://www.linkedin.com/authwall?trk=qf&original_referer=https://www.google.com/&sessionRedirect=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fpushmonkey
https://www.facebook.com/getpushmonkey/
https://www.instagram.com/get_push_monkey/?hl=en
https://www.elegantthemes.com/blog/resources/push-monkey-a-detailed-overview-and-review
Comments:
Obviously, Push Monkey is a push notification service for you to send alerts to subscribers directly in their browser. What sets Push Monkey apart from services such as Push Crew, Push Assist, and Onesignal is how wide it casts its net among CMSes. Instead of being available only for WordPress, Joomla, and a couple other platforms, Push Monkey is available for pretty much everything. As they put it, “You name it and we have it!” (From WordPress to Magento to WooCommerce (specifically) to Joomla, Shopify, Squarespace, Wix…and so on.)
On top of that, they have a broader spectrum of browsers and such that are supported.
Browsers: Google Chrome, Mozilla Firefox, Apple Safari and Opera
Devices: Desktop, Mobile and Tablet Devices
OS: Windows, Android, Linux and MacOS (OSX)
As you can see, they don’t forget that Opera and Linux have users, too. Gotta appreciate that. What does Push Monkey Do?
In the end, your choice of notification service is going to be dependent on a number of factors. So to break down Push Monkey’s major features so you can see if this is the barrel where you want to put all your monkeys: A Detailed Overview and Review
https://www.elegantthemes.com/blog/resources/push-monkey-a-detailed-overview-and-review
MSRM: b] update by CEO see twitter https://twitter.com/MushroomsInc ; tiny float; Update on acquisitions
Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release | 02/23/2023
ESTERO, FL / ACCESSWIRE / February 23, 2023 / Mushrooms, Inc. (OTC PINK:MSRM) (the "Company") has been quietly making progress within this exciting multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology.
Mushrooms Inc. is developing profitable pathways to sustain the research and development branch which is necessary to achieve viable industrial innovation in this new field.
MSRM is targeting grants specific to their goals, working with pioneers, scientists, and universities, on a global scale to develop scientifically proven products that advance health of body, mind, and environment. They have multiple proposals that they are currently reviewing for their costs to bring to market, timelines, scalability, as well as their positive financial, environmental and health impact. These proposals include a patentable process for the development of mycelium-based building supplies, a patentable process for mushroom related cosmetic and anti-aging skin products, a superfood product not currently seen in the marketplace as well as several remediation projects with new product innovation as an end result. These proposals are being assessed while keeping the progress on an off-shore lab and scientists for an evolved patentable mycelium thread.
GROWTH STRATEGY
In order to offset research costs and time on the industrial development side we are establishing pillars of development outside of the industrial mushroom market through acquisitions and joint ventures. The business model is based on the amazing qualities of mycelium and its networking capabilities as well as its ability to benefit from the network its developing.
CEO Kimberly Carlson shared, "I have been fortunate to connect with amazing pioneers and innovators in differing areas of the Mushroom Market in the US and abroad. Three realities have been consistent with the people behind the businesses and their processes. One is that this business model can bring like-minded companies together in order to benefit and fruit from a shared network under the public umbrella. Secondly, there are natural and substantial cross-points between these companies to mutually benefit from each other while growing as a whole. And the third is that there is a desire for many of these businesses to unite their expertise to others and share from a unified gain. By combining the power of shared ideals and resources through joint ventures, we can move as larger more developed companies do, but without limiting quality and compassion for social and environmental governance."
With a focus on profitability and mutually beneficial cross points, MSRM is assessing partnerships with complimentary businesses which would strategically advance the Company's reach into related markets through joint ventures and M&A activity.
Establishing pillars of development outside of the industrial mushroom market allows for a broad scope of proven profitability and cross-sharing of resources.
We seek to enter partnerships in the Cultivation Market, which includes substrate, spawn production, and fruiting. Cultivation gives life to all market pillars to some degree. It feeds directly into the Mushroom Nutraceutical and Medicinal Psylocibin Market with the addition of extraction, quality testing, product development, and processing. The Medicinal Mushroom Market requires legalization and branches into wellness retreats, treatment certifications and clinics.
MSRM is also evaluating several companies involved in the Myco-Remediation Market which uses fungi to clean oil spills, heavy metals, plastics and other pollutants from soil, water, and the atmosphere. All of these markets relate to the industrial and health innovation that the Company is pursuing in differing aspects and creates a connecting point for acceleration, mutual benefit and market share.
It is the belief of MSRM that connecting these pillars of the mushroom market through joint ventures and acquisitions, while focusing their innovation efforts on the industrial side of the market, will garner cross benefits financially and accelerate timelines during the major research and development phases.
We are simultaneously creating a vertically integrated business model for the businesses involved by aligning strengths between the companies under the umbrella of MSRM.
From an investor perspective, we are creating an avenue for investors to support a larger portion of the mushroom market, establishing a broader financial base of support for and from the networked companies while allowing for a more elastic ability to pivot, expand and connect to new industry pathways as they surface.
Market Opportunity
Mushrooms, Inc. operates in the North American segment of the functional mushroom market in the mycelium material and mushroom supplement product types. According to various industrial research firms, the global functional mushroom market is projected to show a compounded annual growth rate of over 9% for the next five years (Industry Arc and Vantage Market Research). The North American edible mushroom market was worth 11.99 billion in 2023 and is growing at a compounded annual growth rate of 9.48%, forecast to reach 20.91 billion by 2028 (Market Data Forecast). The North American functional mushroom market held 33.8% of the global market in 2020 and is growing at a compounded annual growth rate of 7% (Industry Arc).
Overview
Mushrooms, Inc. is a developing-stage emerging consumer products platform focused on the manufacturing and marketing of highly differentiated mushroom-based materials and functional supplements. The core growth pillars of the Mushrooms, Inc. platform are currently based on developing functional mushroom technologies. As a result of growing consumer demand for innovative, sustainable, and carbon-neutral products, Mushrooms, Inc. plans to grow revenues by penetrating the multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology, as well as expanding our platform to include the creation of supplements based on the proven health benefits of mushrooms.
Mushrooms, Inc. seeks to drive the growth of the bourgeoning functional mushroom industry through product innovation and development. Our current core business activity is environmentally beneficial product innovation utilizing self-growing, fibrous, and natural composite materials with controlled physical properties that can be produced in large quantities. Our product technologies focus on mycelium, the main component of fungi. This emerging biotechnology is used in the creation of carbon neutral products for the building, textile, packaging, and health care industries, as well as in the creation of supplements based on the proven health benefits of mushrooms.
Currently, our research focuses primarily on the significant thermal stability of mycelium materials, a result of mycelium's unique degradation qualities that expand the potential fields of application for mushroom-based products. Mushrooms, Inc.'s long-term goal is to build a strong scalable and widely recognized brand that authentically focuses on sustainable mushroom ingredients and novel functionality stemming from innovative biotech and materials science.
For more information, email info@mushroomsinc.com or visit www.mushroomsinc.com
04/20/2023 Quarterly Report for the period ended March31, 2023
03/06/2023 Attorney Letter with Respect to Current Information - Shell Status Opinion MSRM
03/06/2023 Attorney Letter with Respect to Current Information - MSRM - Current Information Letter
03/06/2023 Annual Report - MSRM 2022 Annual Report
https://www.otcmarkets.com/stock/MSRM/disclosure
Unrestricted shares preserved at 4.8M & Acquisitions...[/
Outstanding Shares 37,985,760 04/22/2023
Restricted 33,162,392 04/22/2023
Unrestricted 4,823,368 04/22/2023
MSRM: b] update by CEO see twitter https://twitter.com/MushroomsInc ; tiny float; Update on acquisitions
Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release | 02/23/2023
ESTERO, FL / ACCESSWIRE / February 23, 2023 / Mushrooms, Inc. (OTC PINK:MSRM) (the "Company") has been quietly making progress within this exciting multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology.
Mushrooms Inc. is developing profitable pathways to sustain the research and development branch which is necessary to achieve viable industrial innovation in this new field.
MSRM is targeting grants specific to their goals, working with pioneers, scientists, and universities, on a global scale to develop scientifically proven products that advance health of body, mind, and environment. They have multiple proposals that they are currently reviewing for their costs to bring to market, timelines, scalability, as well as their positive financial, environmental and health impact. These proposals include a patentable process for the development of mycelium-based building supplies, a patentable process for mushroom related cosmetic and anti-aging skin products, a superfood product not currently seen in the marketplace as well as several remediation projects with new product innovation as an end result. These proposals are being assessed while keeping the progress on an off-shore lab and scientists for an evolved patentable mycelium thread.
GROWTH STRATEGY
In order to offset research costs and time on the industrial development side we are establishing pillars of development outside of the industrial mushroom market through acquisitions and joint ventures. The business model is based on the amazing qualities of mycelium and its networking capabilities as well as its ability to benefit from the network its developing.
CEO Kimberly Carlson shared, "I have been fortunate to connect with amazing pioneers and innovators in differing areas of the Mushroom Market in the US and abroad. Three realities have been consistent with the people behind the businesses and their processes. One is that this business model can bring like-minded companies together in order to benefit and fruit from a shared network under the public umbrella. Secondly, there are natural and substantial cross-points between these companies to mutually benefit from each other while growing as a whole. And the third is that there is a desire for many of these businesses to unite their expertise to others and share from a unified gain. By combining the power of shared ideals and resources through joint ventures, we can move as larger more developed companies do, but without limiting quality and compassion for social and environmental governance."
With a focus on profitability and mutually beneficial cross points, MSRM is assessing partnerships with complimentary businesses which would strategically advance the Company's reach into related markets through joint ventures and M&A activity.
Establishing pillars of development outside of the industrial mushroom market allows for a broad scope of proven profitability and cross-sharing of resources.
We seek to enter partnerships in the Cultivation Market, which includes substrate, spawn production, and fruiting. Cultivation gives life to all market pillars to some degree. It feeds directly into the Mushroom Nutraceutical and Medicinal Psylocibin Market with the addition of extraction, quality testing, product development, and processing. The Medicinal Mushroom Market requires legalization and branches into wellness retreats, treatment certifications and clinics.
MSRM is also evaluating several companies involved in the Myco-Remediation Market which uses fungi to clean oil spills, heavy metals, plastics and other pollutants from soil, water, and the atmosphere. All of these markets relate to the industrial and health innovation that the Company is pursuing in differing aspects and creates a connecting point for acceleration, mutual benefit and market share.
It is the belief of MSRM that connecting these pillars of the mushroom market through joint ventures and acquisitions, while focusing their innovation efforts on the industrial side of the market, will garner cross benefits financially and accelerate timelines during the major research and development phases.
We are simultaneously creating a vertically integrated business model for the businesses involved by aligning strengths between the companies under the umbrella of MSRM.
From an investor perspective, we are creating an avenue for investors to support a larger portion of the mushroom market, establishing a broader financial base of support for and from the networked companies while allowing for a more elastic ability to pivot, expand and connect to new industry pathways as they surface.
Market Opportunity
Mushrooms, Inc. operates in the North American segment of the functional mushroom market in the mycelium material and mushroom supplement product types. According to various industrial research firms, the global functional mushroom market is projected to show a compounded annual growth rate of over 9% for the next five years (Industry Arc and Vantage Market Research). The North American edible mushroom market was worth 11.99 billion in 2023 and is growing at a compounded annual growth rate of 9.48%, forecast to reach 20.91 billion by 2028 (Market Data Forecast). The North American functional mushroom market held 33.8% of the global market in 2020 and is growing at a compounded annual growth rate of 7% (Industry Arc).
Overview
Mushrooms, Inc. is a developing-stage emerging consumer products platform focused on the manufacturing and marketing of highly differentiated mushroom-based materials and functional supplements. The core growth pillars of the Mushrooms, Inc. platform are currently based on developing functional mushroom technologies. As a result of growing consumer demand for innovative, sustainable, and carbon-neutral products, Mushrooms, Inc. plans to grow revenues by penetrating the multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology, as well as expanding our platform to include the creation of supplements based on the proven health benefits of mushrooms.
Mushrooms, Inc. seeks to drive the growth of the bourgeoning functional mushroom industry through product innovation and development. Our current core business activity is environmentally beneficial product innovation utilizing self-growing, fibrous, and natural composite materials with controlled physical properties that can be produced in large quantities. Our product technologies focus on mycelium, the main component of fungi. This emerging biotechnology is used in the creation of carbon neutral products for the building, textile, packaging, and health care industries, as well as in the creation of supplements based on the proven health benefits of mushrooms.
Currently, our research focuses primarily on the significant thermal stability of mycelium materials, a result of mycelium's unique degradation qualities that expand the potential fields of application for mushroom-based products. Mushrooms, Inc.'s long-term goal is to build a strong scalable and widely recognized brand that authentically focuses on sustainable mushroom ingredients and novel functionality stemming from innovative biotech and materials science.
For more information, email info@mushroomsinc.com or visit www.mushroomsinc.com
04/20/2023 Quarterly Report for the period ended March31, 2023
03/06/2023 Attorney Letter with Respect to Current Information - Shell Status Opinion MSRM
03/06/2023 Attorney Letter with Respect to Current Information - MSRM - Current Information Letter
03/06/2023 Annual Report - MSRM 2022 Annual Report
https://www.otcmarkets.com/stock/MSRM/disclosure
Unrestricted shares preserved at 4.8M & Acquisitions...[/
Outstanding Shares 37,985,760 04/22/2023
Restricted 33,162,392 04/22/2023
Unrestricted 4,823,368 04/22/2023
MSRM: b] tiny float; Update business concept and acquisitions
Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release | 02/23/2023
ESTERO, FL / ACCESSWIRE / February 23, 2023 / Mushrooms, Inc. (OTC PINK:MSRM) (the "Company") has been quietly making progress within this exciting multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology.
Mushrooms Inc. is developing profitable pathways to sustain the research and development branch which is necessary to achieve viable industrial innovation in this new field.
MSRM is targeting grants specific to their goals, working with pioneers, scientists, and universities, on a global scale to develop scientifically proven products that advance health of body, mind, and environment. They have multiple proposals that they are currently reviewing for their costs to bring to market, timelines, scalability, as well as their positive financial, environmental and health impact. These proposals include a patentable process for the development of mycelium-based building supplies, a patentable process for mushroom related cosmetic and anti-aging skin products, a superfood product not currently seen in the marketplace as well as several remediation projects with new product innovation as an end result. These proposals are being assessed while keeping the progress on an off-shore lab and scientists for an evolved patentable mycelium thread.
GROWTH STRATEGY
In order to offset research costs and time on the industrial development side we are establishing pillars of development outside of the industrial mushroom market through acquisitions and joint ventures. The business model is based on the amazing qualities of mycelium and its networking capabilities as well as its ability to benefit from the network its developing.
CEO Kimberly Carlson shared, "I have been fortunate to connect with amazing pioneers and innovators in differing areas of the Mushroom Market in the US and abroad. Three realities have been consistent with the people behind the businesses and their processes. One is that this business model can bring like-minded companies together in order to benefit and fruit from a shared network under the public umbrella. Secondly, there are natural and substantial cross-points between these companies to mutually benefit from each other while growing as a whole. And the third is that there is a desire for many of these businesses to unite their expertise to others and share from a unified gain. By combining the power of shared ideals and resources through joint ventures, we can move as larger more developed companies do, but without limiting quality and compassion for social and environmental governance."
With a focus on profitability and mutually beneficial cross points, MSRM is assessing partnerships with complimentary businesses which would strategically advance the Company's reach into related markets through joint ventures and M&A activity.
Establishing pillars of development outside of the industrial mushroom market allows for a broad scope of proven profitability and cross-sharing of resources.
We seek to enter partnerships in the Cultivation Market, which includes substrate, spawn production, and fruiting. Cultivation gives life to all market pillars to some degree. It feeds directly into the Mushroom Nutraceutical and Medicinal Psylocibin Market with the addition of extraction, quality testing, product development, and processing. The Medicinal Mushroom Market requires legalization and branches into wellness retreats, treatment certifications and clinics.
MSRM is also evaluating several companies involved in the Myco-Remediation Market which uses fungi to clean oil spills, heavy metals, plastics and other pollutants from soil, water, and the atmosphere. All of these markets relate to the industrial and health innovation that the Company is pursuing in differing aspects and creates a connecting point for acceleration, mutual benefit and market share.
It is the belief of MSRM that connecting these pillars of the mushroom market through joint ventures and acquisitions, while focusing their innovation efforts on the industrial side of the market, will garner cross benefits financially and accelerate timelines during the major research and development phases.
We are simultaneously creating a vertically integrated business model for the businesses involved by aligning strengths between the companies under the umbrella of MSRM.
From an investor perspective, we are creating an avenue for investors to support a larger portion of the mushroom market, establishing a broader financial base of support for and from the networked companies while allowing for a more elastic ability to pivot, expand and connect to new industry pathways as they surface.
Market Opportunity
Mushrooms, Inc. operates in the North American segment of the functional mushroom market in the mycelium material and mushroom supplement product types. According to various industrial research firms, the global functional mushroom market is projected to show a compounded annual growth rate of over 9% for the next five years (Industry Arc and Vantage Market Research). The North American edible mushroom market was worth 11.99 billion in 2023 and is growing at a compounded annual growth rate of 9.48%, forecast to reach 20.91 billion by 2028 (Market Data Forecast). The North American functional mushroom market held 33.8% of the global market in 2020 and is growing at a compounded annual growth rate of 7% (Industry Arc).
Overview
Mushrooms, Inc. is a developing-stage emerging consumer products platform focused on the manufacturing and marketing of highly differentiated mushroom-based materials and functional supplements. The core growth pillars of the Mushrooms, Inc. platform are currently based on developing functional mushroom technologies. As a result of growing consumer demand for innovative, sustainable, and carbon-neutral products, Mushrooms, Inc. plans to grow revenues by penetrating the multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology, as well as expanding our platform to include the creation of supplements based on the proven health benefits of mushrooms.
Mushrooms, Inc. seeks to drive the growth of the bourgeoning functional mushroom industry through product innovation and development. Our current core business activity is environmentally beneficial product innovation utilizing self-growing, fibrous, and natural composite materials with controlled physical properties that can be produced in large quantities. Our product technologies focus on mycelium, the main component of fungi. This emerging biotechnology is used in the creation of carbon neutral products for the building, textile, packaging, and health care industries, as well as in the creation of supplements based on the proven health benefits of mushrooms.
Currently, our research focuses primarily on the significant thermal stability of mycelium materials, a result of mycelium's unique degradation qualities that expand the potential fields of application for mushroom-based products. Mushrooms, Inc.'s long-term goal is to build a strong scalable and widely recognized brand that authentically focuses on sustainable mushroom ingredients and novel functionality stemming from innovative biotech and materials science.
For more information, email info@mushroomsinc.com or visit www.mushroomsinc.com
04/20/2023 Quarterly Report for the period ended March31, 2023
03/06/2023 Attorney Letter with Respect to Current Information - Shell Status Opinion MSRM
03/06/2023 Attorney Letter with Respect to Current Information - MSRM - Current Information Letter
03/06/2023 Annual Report - MSRM 2022 Annual Report
https://www.otcmarkets.com/stock/MSRM/disclosure
Unrestricted shares preserved at 4.8M & Acquisitions...[/
Outstanding Shares 37,985,760 04/22/2023
Restricted 33,162,392 04/22/2023
Unrestricted 4,823,368 04/22/2023
update by CEO:
see twitter https://twitter.com/MushroomsInc
MSRM: b] tiny float; Update business concept and acquisitions
Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release | 02/23/2023
ESTERO, FL / ACCESSWIRE / February 23, 2023 / Mushrooms, Inc. (OTC PINK:MSRM) (the "Company") has been quietly making progress within this exciting multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology.
Mushrooms Inc. is developing profitable pathways to sustain the research and development branch which is necessary to achieve viable industrial innovation in this new field.
MSRM is targeting grants specific to their goals, working with pioneers, scientists, and universities, on a global scale to develop scientifically proven products that advance health of body, mind, and environment. They have multiple proposals that they are currently reviewing for their costs to bring to market, timelines, scalability, as well as their positive financial, environmental and health impact. These proposals include a patentable process for the development of mycelium-based building supplies, a patentable process for mushroom related cosmetic and anti-aging skin products, a superfood product not currently seen in the marketplace as well as several remediation projects with new product innovation as an end result. These proposals are being assessed while keeping the progress on an off-shore lab and scientists for an evolved patentable mycelium thread.
GROWTH STRATEGY
In order to offset research costs and time on the industrial development side we are establishing pillars of development outside of the industrial mushroom market through acquisitions and joint ventures. The business model is based on the amazing qualities of mycelium and its networking capabilities as well as its ability to benefit from the network its developing.
CEO Kimberly Carlson shared, "I have been fortunate to connect with amazing pioneers and innovators in differing areas of the Mushroom Market in the US and abroad. Three realities have been consistent with the people behind the businesses and their processes. One is that this business model can bring like-minded companies together in order to benefit and fruit from a shared network under the public umbrella. Secondly, there are natural and substantial cross-points between these companies to mutually benefit from each other while growing as a whole. And the third is that there is a desire for many of these businesses to unite their expertise to others and share from a unified gain. By combining the power of shared ideals and resources through joint ventures, we can move as larger more developed companies do, but without limiting quality and compassion for social and environmental governance."
With a focus on profitability and mutually beneficial cross points, MSRM is assessing partnerships with complimentary businesses which would strategically advance the Company's reach into related markets through joint ventures and M&A activity.
Establishing pillars of development outside of the industrial mushroom market allows for a broad scope of proven profitability and cross-sharing of resources.
We seek to enter partnerships in the Cultivation Market, which includes substrate, spawn production, and fruiting. Cultivation gives life to all market pillars to some degree. It feeds directly into the Mushroom Nutraceutical and Medicinal Psylocibin Market with the addition of extraction, quality testing, product development, and processing. The Medicinal Mushroom Market requires legalization and branches into wellness retreats, treatment certifications and clinics.
MSRM is also evaluating several companies involved in the Myco-Remediation Market which uses fungi to clean oil spills, heavy metals, plastics and other pollutants from soil, water, and the atmosphere. All of these markets relate to the industrial and health innovation that the Company is pursuing in differing aspects and creates a connecting point for acceleration, mutual benefit and market share.
It is the belief of MSRM that connecting these pillars of the mushroom market through joint ventures and acquisitions, while focusing their innovation efforts on the industrial side of the market, will garner cross benefits financially and accelerate timelines during the major research and development phases.
We are simultaneously creating a vertically integrated business model for the businesses involved by aligning strengths between the companies under the umbrella of MSRM.
From an investor perspective, we are creating an avenue for investors to support a larger portion of the mushroom market, establishing a broader financial base of support for and from the networked companies while allowing for a more elastic ability to pivot, expand and connect to new industry pathways as they surface.
Market Opportunity
Mushrooms, Inc. operates in the North American segment of the functional mushroom market in the mycelium material and mushroom supplement product types. According to various industrial research firms, the global functional mushroom market is projected to show a compounded annual growth rate of over 9% for the next five years (Industry Arc and Vantage Market Research). The North American edible mushroom market was worth 11.99 billion in 2023 and is growing at a compounded annual growth rate of 9.48%, forecast to reach 20.91 billion by 2028 (Market Data Forecast). The North American functional mushroom market held 33.8% of the global market in 2020 and is growing at a compounded annual growth rate of 7% (Industry Arc).
Overview
Mushrooms, Inc. is a developing-stage emerging consumer products platform focused on the manufacturing and marketing of highly differentiated mushroom-based materials and functional supplements. The core growth pillars of the Mushrooms, Inc. platform are currently based on developing functional mushroom technologies. As a result of growing consumer demand for innovative, sustainable, and carbon-neutral products, Mushrooms, Inc. plans to grow revenues by penetrating the multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology, as well as expanding our platform to include the creation of supplements based on the proven health benefits of mushrooms.
Mushrooms, Inc. seeks to drive the growth of the bourgeoning functional mushroom industry through product innovation and development. Our current core business activity is environmentally beneficial product innovation utilizing self-growing, fibrous, and natural composite materials with controlled physical properties that can be produced in large quantities. Our product technologies focus on mycelium, the main component of fungi. This emerging biotechnology is used in the creation of carbon neutral products for the building, textile, packaging, and health care industries, as well as in the creation of supplements based on the proven health benefits of mushrooms.
Currently, our research focuses primarily on the significant thermal stability of mycelium materials, a result of mycelium's unique degradation qualities that expand the potential fields of application for mushroom-based products. Mushrooms, Inc.'s long-term goal is to build a strong scalable and widely recognized brand that authentically focuses on sustainable mushroom ingredients and novel functionality stemming from innovative biotech and materials science.
For more information, email info@mushroomsinc.com or visit www.mushroomsinc.com
04/20/2023 Quarterly Report for the period ended March31, 2023
03/06/2023 Attorney Letter with Respect to Current Information - Shell Status Opinion MSRM
03/06/2023 Attorney Letter with Respect to Current Information - MSRM - Current Information Letter
03/06/2023 Annual Report - MSRM 2022 Annual Report
https://www.otcmarkets.com/stock/MSRM/disclosure
Unrestricted shares preserved at 4.8M & Acquisitions...[/
Outstanding Shares 37,985,760 04/22/2023
Restricted 33,162,392 04/22/2023
Unrestricted 4,823,368 04/22/2023
update by CEO:
see twitter https://twitter.com/MushroomsInc
MSRM: b]
Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release | 02/23/2023
ESTERO, FL / ACCESSWIRE / February 23, 2023 / Mushrooms, Inc. (OTC PINK:MSRM) (the "Company") has been quietly making progress within this exciting multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology.
Mushrooms Inc. is developing profitable pathways to sustain the research and development branch which is necessary to achieve viable industrial innovation in this new field.
MSRM is targeting grants specific to their goals, working with pioneers, scientists, and universities, on a global scale to develop scientifically proven products that advance health of body, mind, and environment. They have multiple proposals that they are currently reviewing for their costs to bring to market, timelines, scalability, as well as their positive financial, environmental and health impact. These proposals include a patentable process for the development of mycelium-based building supplies, a patentable process for mushroom related cosmetic and anti-aging skin products, a superfood product not currently seen in the marketplace as well as several remediation projects with new product innovation as an end result. These proposals are being assessed while keeping the progress on an off-shore lab and scientists for an evolved patentable mycelium thread.
GROWTH STRATEGY
In order to offset research costs and time on the industrial development side we are establishing pillars of development outside of the industrial mushroom market through acquisitions and joint ventures. The business model is based on the amazing qualities of mycelium and its networking capabilities as well as its ability to benefit from the network its developing.
CEO Kimberly Carlson shared, "I have been fortunate to connect with amazing pioneers and innovators in differing areas of the Mushroom Market in the US and abroad. Three realities have been consistent with the people behind the businesses and their processes. One is that this business model can bring like-minded companies together in order to benefit and fruit from a shared network under the public umbrella. Secondly, there are natural and substantial cross-points between these companies to mutually benefit from each other while growing as a whole. And the third is that there is a desire for many of these businesses to unite their expertise to others and share from a unified gain. By combining the power of shared ideals and resources through joint ventures, we can move as larger more developed companies do, but without limiting quality and compassion for social and environmental governance."
With a focus on profitability and mutually beneficial cross points, MSRM is assessing partnerships with complimentary businesses which would strategically advance the Company's reach into related markets through joint ventures and M&A activity.
Establishing pillars of development outside of the industrial mushroom market allows for a broad scope of proven profitability and cross-sharing of resources.
We seek to enter partnerships in the Cultivation Market, which includes substrate, spawn production, and fruiting. Cultivation gives life to all market pillars to some degree. It feeds directly into the Mushroom Nutraceutical and Medicinal Psylocibin Market with the addition of extraction, quality testing, product development, and processing. The Medicinal Mushroom Market requires legalization and branches into wellness retreats, treatment certifications and clinics.
MSRM is also evaluating several companies involved in the Myco-Remediation Market which uses fungi to clean oil spills, heavy metals, plastics and other pollutants from soil, water, and the atmosphere. All of these markets relate to the industrial and health innovation that the Company is pursuing in differing aspects and creates a connecting point for acceleration, mutual benefit and market share.
It is the belief of MSRM that connecting these pillars of the mushroom market through joint ventures and acquisitions, while focusing their innovation efforts on the industrial side of the market, will garner cross benefits financially and accelerate timelines during the major research and development phases.
We are simultaneously creating a vertically integrated business model for the businesses involved by aligning strengths between the companies under the umbrella of MSRM.
From an investor perspective, we are creating an avenue for investors to support a larger portion of the mushroom market, establishing a broader financial base of support for and from the networked companies while allowing for a more elastic ability to pivot, expand and connect to new industry pathways as they surface.
Market Opportunity
Mushrooms, Inc. operates in the North American segment of the functional mushroom market in the mycelium material and mushroom supplement product types. According to various industrial research firms, the global functional mushroom market is projected to show a compounded annual growth rate of over 9% for the next five years (Industry Arc and Vantage Market Research). The North American edible mushroom market was worth 11.99 billion in 2023 and is growing at a compounded annual growth rate of 9.48%, forecast to reach 20.91 billion by 2028 (Market Data Forecast). The North American functional mushroom market held 33.8% of the global market in 2020 and is growing at a compounded annual growth rate of 7% (Industry Arc).
Overview
Mushrooms, Inc. is a developing-stage emerging consumer products platform focused on the manufacturing and marketing of highly differentiated mushroom-based materials and functional supplements. The core growth pillars of the Mushrooms, Inc. platform are currently based on developing functional mushroom technologies. As a result of growing consumer demand for innovative, sustainable, and carbon-neutral products, Mushrooms, Inc. plans to grow revenues by penetrating the multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology, as well as expanding our platform to include the creation of supplements based on the proven health benefits of mushrooms.
Mushrooms, Inc. seeks to drive the growth of the bourgeoning functional mushroom industry through product innovation and development. Our current core business activity is environmentally beneficial product innovation utilizing self-growing, fibrous, and natural composite materials with controlled physical properties that can be produced in large quantities. Our product technologies focus on mycelium, the main component of fungi. This emerging biotechnology is used in the creation of carbon neutral products for the building, textile, packaging, and health care industries, as well as in the creation of supplements based on the proven health benefits of mushrooms.
Currently, our research focuses primarily on the significant thermal stability of mycelium materials, a result of mycelium's unique degradation qualities that expand the potential fields of application for mushroom-based products. Mushrooms, Inc.'s long-term goal is to build a strong scalable and widely recognized brand that authentically focuses on sustainable mushroom ingredients and novel functionality stemming from innovative biotech and materials science.
For more information, email info@mushroomsinc.com or visit www.mushroomsinc.com
04/20/2023 Quarterly Report for the period ended March31, 2023
03/06/2023 Attorney Letter with Respect to Current Information - Shell Status Opinion MSRM
03/06/2023 Attorney Letter with Respect to Current Information - MSRM - Current Information Letter
03/06/2023 Annual Report - MSRM 2022 Annual Report
https://www.otcmarkets.com/stock/MSRM/disclosure
Unrestricted shares preserved at 4.8M & Acquisitions...[/
Outstanding Shares 37,985,760 04/22/2023
Restricted 33,162,392 04/22/2023
Unrestricted 4,823,368 04/22/2023
update by CEO:
see twitter https://twitter.com/MushroomsInc
MSRM: b] Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release | 02/23/2023
ESTERO, FL / ACCESSWIRE / February 23, 2023 / Mushrooms, Inc. (OTC PINK:MSRM) (the "Company") has been quietly making progress within this exciting multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology.
Mushrooms Inc. is developing profitable pathways to sustain the research and development branch which is necessary to achieve viable industrial innovation in this new field.
MSRM is targeting grants specific to their goals, working with pioneers, scientists, and universities, on a global scale to develop scientifically proven products that advance health of body, mind, and environment. They have multiple proposals that they are currently reviewing for their costs to bring to market, timelines, scalability, as well as their positive financial, environmental and health impact. These proposals include a patentable process for the development of mycelium-based building supplies, a patentable process for mushroom related cosmetic and anti-aging skin products, a superfood product not currently seen in the marketplace as well as several remediation projects with new product innovation as an end result. These proposals are being assessed while keeping the progress on an off-shore lab and scientists for an evolved patentable mycelium thread.
GROWTH STRATEGY
In order to offset research costs and time on the industrial development side we are establishing pillars of development outside of the industrial mushroom market through acquisitions and joint ventures. The business model is based on the amazing qualities of mycelium and its networking capabilities as well as its ability to benefit from the network its developing.
CEO Kimberly Carlson shared, "I have been fortunate to connect with amazing pioneers and innovators in differing areas of the Mushroom Market in the US and abroad. Three realities have been consistent with the people behind the businesses and their processes. One is that this business model can bring like-minded companies together in order to benefit and fruit from a shared network under the public umbrella. Secondly, there are natural and substantial cross-points between these companies to mutually benefit from each other while growing as a whole. And the third is that there is a desire for many of these businesses to unite their expertise to others and share from a unified gain. By combining the power of shared ideals and resources through joint ventures, we can move as larger more developed companies do, but without limiting quality and compassion for social and environmental governance."
With a focus on profitability and mutually beneficial cross points, MSRM is assessing partnerships with complimentary businesses which would strategically advance the Company's reach into related markets through joint ventures and M&A activity.
Establishing pillars of development outside of the industrial mushroom market allows for a broad scope of proven profitability and cross-sharing of resources.
We seek to enter partnerships in the Cultivation Market, which includes substrate, spawn production, and fruiting. Cultivation gives life to all market pillars to some degree. It feeds directly into the Mushroom Nutraceutical and Medicinal Psylocibin Market with the addition of extraction, quality testing, product development, and processing. The Medicinal Mushroom Market requires legalization and branches into wellness retreats, treatment certifications and clinics.
MSRM is also evaluating several companies involved in the Myco-Remediation Market which uses fungi to clean oil spills, heavy metals, plastics and other pollutants from soil, water, and the atmosphere. All of these markets relate to the industrial and health innovation that the Company is pursuing in differing aspects and creates a connecting point for acceleration, mutual benefit and market share.
It is the belief of MSRM that connecting these pillars of the mushroom market through joint ventures and acquisitions, while focusing their innovation efforts on the industrial side of the market, will garner cross benefits financially and accelerate timelines during the major research and development phases.
We are simultaneously creating a vertically integrated business model for the businesses involved by aligning strengths between the companies under the umbrella of MSRM.
From an investor perspective, we are creating an avenue for investors to support a larger portion of the mushroom market, establishing a broader financial base of support for and from the networked companies while allowing for a more elastic ability to pivot, expand and connect to new industry pathways as they surface.
Market Opportunity
Mushrooms, Inc. operates in the North American segment of the functional mushroom market in the mycelium material and mushroom supplement product types. According to various industrial research firms, the global functional mushroom market is projected to show a compounded annual growth rate of over 9% for the next five years (Industry Arc and Vantage Market Research). The North American edible mushroom market was worth 11.99 billion in 2023 and is growing at a compounded annual growth rate of 9.48%, forecast to reach 20.91 billion by 2028 (Market Data Forecast). The North American functional mushroom market held 33.8% of the global market in 2020 and is growing at a compounded annual growth rate of 7% (Industry Arc).
Overview
Mushrooms, Inc. is a developing-stage emerging consumer products platform focused on the manufacturing and marketing of highly differentiated mushroom-based materials and functional supplements. The core growth pillars of the Mushrooms, Inc. platform are currently based on developing functional mushroom technologies. As a result of growing consumer demand for innovative, sustainable, and carbon-neutral products, Mushrooms, Inc. plans to grow revenues by penetrating the multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology, as well as expanding our platform to include the creation of supplements based on the proven health benefits of mushrooms.
Mushrooms, Inc. seeks to drive the growth of the bourgeoning functional mushroom industry through product innovation and development. Our current core business activity is environmentally beneficial product innovation utilizing self-growing, fibrous, and natural composite materials with controlled physical properties that can be produced in large quantities. Our product technologies focus on mycelium, the main component of fungi. This emerging biotechnology is used in the creation of carbon neutral products for the building, textile, packaging, and health care industries, as well as in the creation of supplements based on the proven health benefits of mushrooms.
Currently, our research focuses primarily on the significant thermal stability of mycelium materials, a result of mycelium's unique degradation qualities that expand the potential fields of application for mushroom-based products. Mushrooms, Inc.'s long-term goal is to build a strong scalable and widely recognized brand that authentically focuses on sustainable mushroom ingredients and novel functionality stemming from innovative biotech and materials science.
For more information, email info@mushroomsinc.com or visit www.mushroomsinc.com
04/20/2023 Quarterly Report for the period ended March31, 2023
03/06/2023 Attorney Letter with Respect to Current Information - Shell Status Opinion MSRM
03/06/2023 Attorney Letter with Respect to Current Information - MSRM - Current Information Letter
03/06/2023 Annual Report - MSRM 2022 Annual Report
https://www.otcmarkets.com/stock/MSRM/disclosure
Unrestricted shares preserved at 4.8M & Acquisitions...[/
Outstanding Shares 37,985,760 04/22/2023
Restricted 33,162,392 04/22/2023
Unrestricted 4,823,368 04/22/2023
update by CEO:
see twitter https://twitter.com/MushroomsInc
MSRM: Unrestricted shares preserved at 4.8M & Acquisitions...
Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release | 02/23/2023
ESTERO, FL / ACCESSWIRE / February 23, 2023 / Mushrooms, Inc. (OTC PINK:MSRM) (the "Company") has been quietly making progress within this exciting multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology.
Mushrooms Inc. is developing profitable pathways to sustain the research and development branch which is necessary to achieve viable industrial innovation in this new field.
MSRM is targeting grants specific to their goals, working with pioneers, scientists, and universities, on a global scale to develop scientifically proven products that advance health of body, mind, and environment. They have multiple proposals that they are currently reviewing for their costs to bring to market, timelines, scalability, as well as their positive financial, environmental and health impact. These proposals include a patentable process for the development of mycelium-based building supplies, a patentable process for mushroom related cosmetic and anti-aging skin products, a superfood product not currently seen in the marketplace as well as several remediation projects with new product innovation as an end result. These proposals are being assessed while keeping the progress on an off-shore lab and scientists for an evolved patentable mycelium thread.
GROWTH STRATEGY
In order to offset research costs and time on the industrial development side we are establishing pillars of development outside of the industrial mushroom market through acquisitions and joint ventures. The business model is based on the amazing qualities of mycelium and its networking capabilities as well as its ability to benefit from the network its developing.
CEO Kimberly Carlson shared, "I have been fortunate to connect with amazing pioneers and innovators in differing areas of the Mushroom Market in the US and abroad. Three realities have been consistent with the people behind the businesses and their processes. One is that this business model can bring like-minded companies together in order to benefit and fruit from a shared network under the public umbrella. Secondly, there are natural and substantial cross-points between these companies to mutually benefit from each other while growing as a whole. And the third is that there is a desire for many of these businesses to unite their expertise to others and share from a unified gain. By combining the power of shared ideals and resources through joint ventures, we can move as larger more developed companies do, but without limiting quality and compassion for social and environmental governance."
With a focus on profitability and mutually beneficial cross points, MSRM is assessing partnerships with complimentary businesses which would strategically advance the Company's reach into related markets through joint ventures and M&A activity.
Establishing pillars of development outside of the industrial mushroom market allows for a broad scope of proven profitability and cross-sharing of resources.
We seek to enter partnerships in the Cultivation Market, which includes substrate, spawn production, and fruiting. Cultivation gives life to all market pillars to some degree. It feeds directly into the Mushroom Nutraceutical and Medicinal Psylocibin Market with the addition of extraction, quality testing, product development, and processing. The Medicinal Mushroom Market requires legalization and branches into wellness retreats, treatment certifications and clinics.
MSRM is also evaluating several companies involved in the Myco-Remediation Market which uses fungi to clean oil spills, heavy metals, plastics and other pollutants from soil, water, and the atmosphere. All of these markets relate to the industrial and health innovation that the Company is pursuing in differing aspects and creates a connecting point for acceleration, mutual benefit and market share.
It is the belief of MSRM that connecting these pillars of the mushroom market through joint ventures and acquisitions, while focusing their innovation efforts on the industrial side of the market, will garner cross benefits financially and accelerate timelines during the major research and development phases.
We are simultaneously creating a vertically integrated business model for the businesses involved by aligning strengths between the companies under the umbrella of MSRM.
From an investor perspective, we are creating an avenue for investors to support a larger portion of the mushroom market, establishing a broader financial base of support for and from the networked companies while allowing for a more elastic ability to pivot, expand and connect to new industry pathways as they surface.
Market Opportunity
Mushrooms, Inc. operates in the North American segment of the functional mushroom market in the mycelium material and mushroom supplement product types. According to various industrial research firms, the global functional mushroom market is projected to show a compounded annual growth rate of over 9% for the next five years (Industry Arc and Vantage Market Research). The North American edible mushroom market was worth 11.99 billion in 2023 and is growing at a compounded annual growth rate of 9.48%, forecast to reach 20.91 billion by 2028 (Market Data Forecast). The North American functional mushroom market held 33.8% of the global market in 2020 and is growing at a compounded annual growth rate of 7% (Industry Arc).
Overview
Mushrooms, Inc. is a developing-stage emerging consumer products platform focused on the manufacturing and marketing of highly differentiated mushroom-based materials and functional supplements. The core growth pillars of the Mushrooms, Inc. platform are currently based on developing functional mushroom technologies. As a result of growing consumer demand for innovative, sustainable, and carbon-neutral products, Mushrooms, Inc. plans to grow revenues by penetrating the multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology, as well as expanding our platform to include the creation of supplements based on the proven health benefits of mushrooms.
Mushrooms, Inc. seeks to drive the growth of the bourgeoning functional mushroom industry through product innovation and development. Our current core business activity is environmentally beneficial product innovation utilizing self-growing, fibrous, and natural composite materials with controlled physical properties that can be produced in large quantities. Our product technologies focus on mycelium, the main component of fungi. This emerging biotechnology is used in the creation of carbon neutral products for the building, textile, packaging, and health care industries, as well as in the creation of supplements based on the proven health benefits of mushrooms.
Currently, our research focuses primarily on the significant thermal stability of mycelium materials, a result of mycelium's unique degradation qualities that expand the potential fields of application for mushroom-based products. Mushrooms, Inc.'s long-term goal is to build a strong scalable and widely recognized brand that authentically focuses on sustainable mushroom ingredients and novel functionality stemming from innovative biotech and materials science.
For more information, email info@mushroomsinc.com or visit www.mushroomsinc.com
04/20/2023 Quarterly Report for the period ended March31, 2023
03/06/2023 Attorney Letter with Respect to Current Information - Shell Status Opinion MSRM
03/06/2023 Attorney Letter with Respect to Current Information - MSRM - Current Information Letter
03/06/2023 Annual Report - MSRM 2022 Annual Report
https://www.otcmarkets.com/stock/MSRM/disclosure
Outstanding Shares 37,985,760 04/22/2023
Restricted 33,162,392 04/22/2023
Unrestricted 4,823,368 04/22/2023
update by CEO:
see twitter https://twitter.com/MushroomsInc
MSRM: Unrestricted shares preserved at 4.8M & Acquisitions...
Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release | 02/23/2023
ESTERO, FL / ACCESSWIRE / February 23, 2023 / Mushrooms, Inc. (OTC PINK:MSRM) (the "Company") has been quietly making progress within this exciting multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology.
Mushrooms Inc. is developing profitable pathways to sustain the research and development branch which is necessary to achieve viable industrial innovation in this new field.
MSRM is targeting grants specific to their goals, working with pioneers, scientists, and universities, on a global scale to develop scientifically proven products that advance health of body, mind, and environment. They have multiple proposals that they are currently reviewing for their costs to bring to market, timelines, scalability, as well as their positive financial, environmental and health impact. These proposals include a patentable process for the development of mycelium-based building supplies, a patentable process for mushroom related cosmetic and anti-aging skin products, a superfood product not currently seen in the marketplace as well as several remediation projects with new product innovation as an end result. These proposals are being assessed while keeping the progress on an off-shore lab and scientists for an evolved patentable mycelium thread.
GROWTH STRATEGY
In order to offset research costs and time on the industrial development side we are establishing pillars of development outside of the industrial mushroom market through acquisitions and joint ventures. The business model is based on the amazing qualities of mycelium and its networking capabilities as well as its ability to benefit from the network its developing.
CEO Kimberly Carlson shared, "I have been fortunate to connect with amazing pioneers and innovators in differing areas of the Mushroom Market in the US and abroad. Three realities have been consistent with the people behind the businesses and their processes. One is that this business model can bring like-minded companies together in order to benefit and fruit from a shared network under the public umbrella. Secondly, there are natural and substantial cross-points between these companies to mutually benefit from each other while growing as a whole. And the third is that there is a desire for many of these businesses to unite their expertise to others and share from a unified gain. By combining the power of shared ideals and resources through joint ventures, we can move as larger more developed companies do, but without limiting quality and compassion for social and environmental governance."
With a focus on profitability and mutually beneficial cross points, MSRM is assessing partnerships with complimentary businesses which would strategically advance the Company's reach into related markets through joint ventures and M&A activity.
Establishing pillars of development outside of the industrial mushroom market allows for a broad scope of proven profitability and cross-sharing of resources.
We seek to enter partnerships in the Cultivation Market, which includes substrate, spawn production, and fruiting. Cultivation gives life to all market pillars to some degree. It feeds directly into the Mushroom Nutraceutical and Medicinal Psylocibin Market with the addition of extraction, quality testing, product development, and processing. The Medicinal Mushroom Market requires legalization and branches into wellness retreats, treatment certifications and clinics.
MSRM is also evaluating several companies involved in the Myco-Remediation Market which uses fungi to clean oil spills, heavy metals, plastics and other pollutants from soil, water, and the atmosphere. All of these markets relate to the industrial and health innovation that the Company is pursuing in differing aspects and creates a connecting point for acceleration, mutual benefit and market share.
It is the belief of MSRM that connecting these pillars of the mushroom market through joint ventures and acquisitions, while focusing their innovation efforts on the industrial side of the market, will garner cross benefits financially and accelerate timelines during the major research and development phases.
We are simultaneously creating a vertically integrated business model for the businesses involved by aligning strengths between the companies under the umbrella of MSRM.
From an investor perspective, we are creating an avenue for investors to support a larger portion of the mushroom market, establishing a broader financial base of support for and from the networked companies while allowing for a more elastic ability to pivot, expand and connect to new industry pathways as they surface.
Market Opportunity
Mushrooms, Inc. operates in the North American segment of the functional mushroom market in the mycelium material and mushroom supplement product types. According to various industrial research firms, the global functional mushroom market is projected to show a compounded annual growth rate of over 9% for the next five years (Industry Arc and Vantage Market Research). The North American edible mushroom market was worth 11.99 billion in 2023 and is growing at a compounded annual growth rate of 9.48%, forecast to reach 20.91 billion by 2028 (Market Data Forecast). The North American functional mushroom market held 33.8% of the global market in 2020 and is growing at a compounded annual growth rate of 7% (Industry Arc).
Overview
Mushrooms, Inc. is a developing-stage emerging consumer products platform focused on the manufacturing and marketing of highly differentiated mushroom-based materials and functional supplements. The core growth pillars of the Mushrooms, Inc. platform are currently based on developing functional mushroom technologies. As a result of growing consumer demand for innovative, sustainable, and carbon-neutral products, Mushrooms, Inc. plans to grow revenues by penetrating the multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology, as well as expanding our platform to include the creation of supplements based on the proven health benefits of mushrooms.
Mushrooms, Inc. seeks to drive the growth of the bourgeoning functional mushroom industry through product innovation and development. Our current core business activity is environmentally beneficial product innovation utilizing self-growing, fibrous, and natural composite materials with controlled physical properties that can be produced in large quantities. Our product technologies focus on mycelium, the main component of fungi. This emerging biotechnology is used in the creation of carbon neutral products for the building, textile, packaging, and health care industries, as well as in the creation of supplements based on the proven health benefits of mushrooms.
Currently, our research focuses primarily on the significant thermal stability of mycelium materials, a result of mycelium's unique degradation qualities that expand the potential fields of application for mushroom-based products. Mushrooms, Inc.'s long-term goal is to build a strong scalable and widely recognized brand that authentically focuses on sustainable mushroom ingredients and novel functionality stemming from innovative biotech and materials science.
For more information, email info@mushroomsinc.com or visit www.mushroomsinc.com
04/20/2023 Quarterly Report for the period ended March31, 2023
03/06/2023 Attorney Letter with Respect to Current Information - Shell Status Opinion MSRM
03/06/2023 Attorney Letter with Respect to Current Information - MSRM - Current Information Letter
03/06/2023 Annual Report - MSRM 2022 Annual Report
https://www.otcmarkets.com/stock/MSRM/disclosure
Outstanding Shares 37,985,760 04/22/2023
Restricted 33,162,392 04/22/2023
Unrestricted 4,823,368 04/22/2023
update by CEO:
see twitter https://twitter.com/MushroomsInc
MSRM: Acquisitions...Unrestricted shares preserved at 4.8M
Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release | 02/23/2023
ESTERO, FL / ACCESSWIRE / February 23, 2023 / Mushrooms, Inc. (OTC PINK:MSRM) (the "Company") has been quietly making progress within this exciting multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology.
Mushrooms Inc. is developing profitable pathways to sustain the research and development branch which is necessary to achieve viable industrial innovation in this new field.
MSRM is targeting grants specific to their goals, working with pioneers, scientists, and universities, on a global scale to develop scientifically proven products that advance health of body, mind, and environment. They have multiple proposals that they are currently reviewing for their costs to bring to market, timelines, scalability, as well as their positive financial, environmental and health impact. These proposals include a patentable process for the development of mycelium-based building supplies, a patentable process for mushroom related cosmetic and anti-aging skin products, a superfood product not currently seen in the marketplace as well as several remediation projects with new product innovation as an end result. These proposals are being assessed while keeping the progress on an off-shore lab and scientists for an evolved patentable mycelium thread.
GROWTH STRATEGY
In order to offset research costs and time on the industrial development side we are establishing pillars of development outside of the industrial mushroom market through acquisitions and joint ventures. The business model is based on the amazing qualities of mycelium and its networking capabilities as well as its ability to benefit from the network its developing.
CEO Kimberly Carlson shared, "I have been fortunate to connect with amazing pioneers and innovators in differing areas of the Mushroom Market in the US and abroad. Three realities have been consistent with the people behind the businesses and their processes. One is that this business model can bring like-minded companies together in order to benefit and fruit from a shared network under the public umbrella. Secondly, there are natural and substantial cross-points between these companies to mutually benefit from each other while growing as a whole. And the third is that there is a desire for many of these businesses to unite their expertise to others and share from a unified gain. By combining the power of shared ideals and resources through joint ventures, we can move as larger more developed companies do, but without limiting quality and compassion for social and environmental governance."
With a focus on profitability and mutually beneficial cross points, MSRM is assessing partnerships with complimentary businesses which would strategically advance the Company's reach into related markets through joint ventures and M&A activity.
Establishing pillars of development outside of the industrial mushroom market allows for a broad scope of proven profitability and cross-sharing of resources.
We seek to enter partnerships in the Cultivation Market, which includes substrate, spawn production, and fruiting. Cultivation gives life to all market pillars to some degree. It feeds directly into the Mushroom Nutraceutical and Medicinal Psylocibin Market with the addition of extraction, quality testing, product development, and processing. The Medicinal Mushroom Market requires legalization and branches into wellness retreats, treatment certifications and clinics.
MSRM is also evaluating several companies involved in the Myco-Remediation Market which uses fungi to clean oil spills, heavy metals, plastics and other pollutants from soil, water, and the atmosphere. All of these markets relate to the industrial and health innovation that the Company is pursuing in differing aspects and creates a connecting point for acceleration, mutual benefit and market share.
It is the belief of MSRM that connecting these pillars of the mushroom market through joint ventures and acquisitions, while focusing their innovation efforts on the industrial side of the market, will garner cross benefits financially and accelerate timelines during the major research and development phases.
We are simultaneously creating a vertically integrated business model for the businesses involved by aligning strengths between the companies under the umbrella of MSRM.
From an investor perspective, we are creating an avenue for investors to support a larger portion of the mushroom market, establishing a broader financial base of support for and from the networked companies while allowing for a more elastic ability to pivot, expand and connect to new industry pathways as they surface.
Market Opportunity
Mushrooms, Inc. operates in the North American segment of the functional mushroom market in the mycelium material and mushroom supplement product types. According to various industrial research firms, the global functional mushroom market is projected to show a compounded annual growth rate of over 9% for the next five years (Industry Arc and Vantage Market Research). The North American edible mushroom market was worth 11.99 billion in 2023 and is growing at a compounded annual growth rate of 9.48%, forecast to reach 20.91 billion by 2028 (Market Data Forecast). The North American functional mushroom market held 33.8% of the global market in 2020 and is growing at a compounded annual growth rate of 7% (Industry Arc).
Overview
Mushrooms, Inc. is a developing-stage emerging consumer products platform focused on the manufacturing and marketing of highly differentiated mushroom-based materials and functional supplements. The core growth pillars of the Mushrooms, Inc. platform are currently based on developing functional mushroom technologies. As a result of growing consumer demand for innovative, sustainable, and carbon-neutral products, Mushrooms, Inc. plans to grow revenues by penetrating the multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology, as well as expanding our platform to include the creation of supplements based on the proven health benefits of mushrooms.
Mushrooms, Inc. seeks to drive the growth of the bourgeoning functional mushroom industry through product innovation and development. Our current core business activity is environmentally beneficial product innovation utilizing self-growing, fibrous, and natural composite materials with controlled physical properties that can be produced in large quantities. Our product technologies focus on mycelium, the main component of fungi. This emerging biotechnology is used in the creation of carbon neutral products for the building, textile, packaging, and health care industries, as well as in the creation of supplements based on the proven health benefits of mushrooms.
Currently, our research focuses primarily on the significant thermal stability of mycelium materials, a result of mycelium's unique degradation qualities that expand the potential fields of application for mushroom-based products. Mushrooms, Inc.'s long-term goal is to build a strong scalable and widely recognized brand that authentically focuses on sustainable mushroom ingredients and novel functionality stemming from innovative biotech and materials science.
For more information, email info@mushroomsinc.com or visit www.mushroomsinc.com
04/20/2023 Quarterly Report for the period ended March31, 2023
03/06/2023 Attorney Letter with Respect to Current Information - Shell Status Opinion MSRM
03/06/2023 Attorney Letter with Respect to Current Information - MSRM - Current Information Letter
03/06/2023 Annual Report - MSRM 2022 Annual Report
https://www.otcmarkets.com/stock/MSRM/disclosure
Outstanding Shares 37,985,760 04/22/2023
Restricted 33,162,392 04/22/2023
Unrestricted 4,823,368 04/22/2023
update by CEO:
see twitter https://twitter.com/MushroomsInc
MSRM: Acquisitions...Unrestricted shares preserved at 4.8M
Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release | 02/23/2023
ESTERO, FL / ACCESSWIRE / February 23, 2023 / Mushrooms, Inc. (OTC PINK:MSRM) (the "Company") has been quietly making progress within this exciting multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology.
Mushrooms Inc. is developing profitable pathways to sustain the research and development branch which is necessary to achieve viable industrial innovation in this new field.
MSRM is targeting grants specific to their goals, working with pioneers, scientists, and universities, on a global scale to develop scientifically proven products that advance health of body, mind, and environment. They have multiple proposals that they are currently reviewing for their costs to bring to market, timelines, scalability, as well as their positive financial, environmental and health impact. These proposals include a patentable process for the development of mycelium-based building supplies, a patentable process for mushroom related cosmetic and anti-aging skin products, a superfood product not currently seen in the marketplace as well as several remediation projects with new product innovation as an end result. These proposals are being assessed while keeping the progress on an off-shore lab and scientists for an evolved patentable mycelium thread.
GROWTH STRATEGY
In order to offset research costs and time on the industrial development side we are establishing pillars of development outside of the industrial mushroom market through acquisitions and joint ventures. The business model is based on the amazing qualities of mycelium and its networking capabilities as well as its ability to benefit from the network its developing.
CEO Kimberly Carlson shared, "I have been fortunate to connect with amazing pioneers and innovators in differing areas of the Mushroom Market in the US and abroad. Three realities have been consistent with the people behind the businesses and their processes. One is that this business model can bring like-minded companies together in order to benefit and fruit from a shared network under the public umbrella. Secondly, there are natural and substantial cross-points between these companies to mutually benefit from each other while growing as a whole. And the third is that there is a desire for many of these businesses to unite their expertise to others and share from a unified gain. By combining the power of shared ideals and resources through joint ventures, we can move as larger more developed companies do, but without limiting quality and compassion for social and environmental governance."
With a focus on profitability and mutually beneficial cross points, MSRM is assessing partnerships with complimentary businesses which would strategically advance the Company's reach into related markets through joint ventures and M&A activity.
Establishing pillars of development outside of the industrial mushroom market allows for a broad scope of proven profitability and cross-sharing of resources.
We seek to enter partnerships in the Cultivation Market, which includes substrate, spawn production, and fruiting. Cultivation gives life to all market pillars to some degree. It feeds directly into the Mushroom Nutraceutical and Medicinal Psylocibin Market with the addition of extraction, quality testing, product development, and processing. The Medicinal Mushroom Market requires legalization and branches into wellness retreats, treatment certifications and clinics.
MSRM is also evaluating several companies involved in the Myco-Remediation Market which uses fungi to clean oil spills, heavy metals, plastics and other pollutants from soil, water, and the atmosphere. All of these markets relate to the industrial and health innovation that the Company is pursuing in differing aspects and creates a connecting point for acceleration, mutual benefit and market share.
It is the belief of MSRM that connecting these pillars of the mushroom market through joint ventures and acquisitions, while focusing their innovation efforts on the industrial side of the market, will garner cross benefits financially and accelerate timelines during the major research and development phases.
We are simultaneously creating a vertically integrated business model for the businesses involved by aligning strengths between the companies under the umbrella of MSRM.
From an investor perspective, we are creating an avenue for investors to support a larger portion of the mushroom market, establishing a broader financial base of support for and from the networked companies while allowing for a more elastic ability to pivot, expand and connect to new industry pathways as they surface.
Market Opportunity
Mushrooms, Inc. operates in the North American segment of the functional mushroom market in the mycelium material and mushroom supplement product types. According to various industrial research firms, the global functional mushroom market is projected to show a compounded annual growth rate of over 9% for the next five years (Industry Arc and Vantage Market Research). The North American edible mushroom market was worth 11.99 billion in 2023 and is growing at a compounded annual growth rate of 9.48%, forecast to reach 20.91 billion by 2028 (Market Data Forecast). The North American functional mushroom market held 33.8% of the global market in 2020 and is growing at a compounded annual growth rate of 7% (Industry Arc).
Overview
Mushrooms, Inc. is a developing-stage emerging consumer products platform focused on the manufacturing and marketing of highly differentiated mushroom-based materials and functional supplements. The core growth pillars of the Mushrooms, Inc. platform are currently based on developing functional mushroom technologies. As a result of growing consumer demand for innovative, sustainable, and carbon-neutral products, Mushrooms, Inc. plans to grow revenues by penetrating the multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology, as well as expanding our platform to include the creation of supplements based on the proven health benefits of mushrooms.
Mushrooms, Inc. seeks to drive the growth of the bourgeoning functional mushroom industry through product innovation and development. Our current core business activity is environmentally beneficial product innovation utilizing self-growing, fibrous, and natural composite materials with controlled physical properties that can be produced in large quantities. Our product technologies focus on mycelium, the main component of fungi. This emerging biotechnology is used in the creation of carbon neutral products for the building, textile, packaging, and health care industries, as well as in the creation of supplements based on the proven health benefits of mushrooms.
Currently, our research focuses primarily on the significant thermal stability of mycelium materials, a result of mycelium's unique degradation qualities that expand the potential fields of application for mushroom-based products. Mushrooms, Inc.'s long-term goal is to build a strong scalable and widely recognized brand that authentically focuses on sustainable mushroom ingredients and novel functionality stemming from innovative biotech and materials science.
For more information, email info@mushroomsinc.com or visit www.mushroomsinc.com
04/20/2023 Quarterly Report for the period ended March31, 2023
03/06/2023 Attorney Letter with Respect to Current Information - Shell Status Opinion MSRM
03/06/2023 Attorney Letter with Respect to Current Information - MSRM - Current Information Letter
03/06/2023 Annual Report - MSRM 2022 Annual Report
https://www.otcmarkets.com/stock/MSRM/disclosure
Outstanding Shares 37,985,760 04/22/2023
Restricted 33,162,392 04/22/2023
Unrestricted 4,823,368 04/22/2023
update by CEO:
see twitter https://twitter.com/MushroomsInc
MSRM: Update & Acquisitions...Unrestricted shares preserved at 4.8M
Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release | 02/23/2023
ESTERO, FL / ACCESSWIRE / February 23, 2023 / Mushrooms, Inc. (OTC PINK:MSRM) (the "Company") has been quietly making progress within this exciting multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology.
Mushrooms Inc. is developing profitable pathways to sustain the research and development branch which is necessary to achieve viable industrial innovation in this new field.
MSRM is targeting grants specific to their goals, working with pioneers, scientists, and universities, on a global scale to develop scientifically proven products that advance health of body, mind, and environment. They have multiple proposals that they are currently reviewing for their costs to bring to market, timelines, scalability, as well as their positive financial, environmental and health impact. These proposals include a patentable process for the development of mycelium-based building supplies, a patentable process for mushroom related cosmetic and anti-aging skin products, a superfood product not currently seen in the marketplace as well as several remediation projects with new product innovation as an end result. These proposals are being assessed while keeping the progress on an off-shore lab and scientists for an evolved patentable mycelium thread.
GROWTH STRATEGY
In order to offset research costs and time on the industrial development side we are establishing pillars of development outside of the industrial mushroom market through acquisitions and joint ventures. The business model is based on the amazing qualities of mycelium and its networking capabilities as well as its ability to benefit from the network its developing.
CEO Kimberly Carlson shared, "I have been fortunate to connect with amazing pioneers and innovators in differing areas of the Mushroom Market in the US and abroad. Three realities have been consistent with the people behind the businesses and their processes. One is that this business model can bring like-minded companies together in order to benefit and fruit from a shared network under the public umbrella. Secondly, there are natural and substantial cross-points between these companies to mutually benefit from each other while growing as a whole. And the third is that there is a desire for many of these businesses to unite their expertise to others and share from a unified gain. By combining the power of shared ideals and resources through joint ventures, we can move as larger more developed companies do, but without limiting quality and compassion for social and environmental governance."
With a focus on profitability and mutually beneficial cross points, MSRM is assessing partnerships with complimentary businesses which would strategically advance the Company's reach into related markets through joint ventures and M&A activity.
Establishing pillars of development outside of the industrial mushroom market allows for a broad scope of proven profitability and cross-sharing of resources.
We seek to enter partnerships in the Cultivation Market, which includes substrate, spawn production, and fruiting. Cultivation gives life to all market pillars to some degree. It feeds directly into the Mushroom Nutraceutical and Medicinal Psylocibin Market with the addition of extraction, quality testing, product development, and processing. The Medicinal Mushroom Market requires legalization and branches into wellness retreats, treatment certifications and clinics.
MSRM is also evaluating several companies involved in the Myco-Remediation Market which uses fungi to clean oil spills, heavy metals, plastics and other pollutants from soil, water, and the atmosphere. All of these markets relate to the industrial and health innovation that the Company is pursuing in differing aspects and creates a connecting point for acceleration, mutual benefit and market share.
It is the belief of MSRM that connecting these pillars of the mushroom market through joint ventures and acquisitions, while focusing their innovation efforts on the industrial side of the market, will garner cross benefits financially and accelerate timelines during the major research and development phases.
We are simultaneously creating a vertically integrated business model for the businesses involved by aligning strengths between the companies under the umbrella of MSRM.
From an investor perspective, we are creating an avenue for investors to support a larger portion of the mushroom market, establishing a broader financial base of support for and from the networked companies while allowing for a more elastic ability to pivot, expand and connect to new industry pathways as they surface.
Market Opportunity
Mushrooms, Inc. operates in the North American segment of the functional mushroom market in the mycelium material and mushroom supplement product types. According to various industrial research firms, the global functional mushroom market is projected to show a compounded annual growth rate of over 9% for the next five years (Industry Arc and Vantage Market Research). The North American edible mushroom market was worth 11.99 billion in 2023 and is growing at a compounded annual growth rate of 9.48%, forecast to reach 20.91 billion by 2028 (Market Data Forecast). The North American functional mushroom market held 33.8% of the global market in 2020 and is growing at a compounded annual growth rate of 7% (Industry Arc).
Overview
Mushrooms, Inc. is a developing-stage emerging consumer products platform focused on the manufacturing and marketing of highly differentiated mushroom-based materials and functional supplements. The core growth pillars of the Mushrooms, Inc. platform are currently based on developing functional mushroom technologies. As a result of growing consumer demand for innovative, sustainable, and carbon-neutral products, Mushrooms, Inc. plans to grow revenues by penetrating the multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology, as well as expanding our platform to include the creation of supplements based on the proven health benefits of mushrooms.
Mushrooms, Inc. seeks to drive the growth of the bourgeoning functional mushroom industry through product innovation and development. Our current core business activity is environmentally beneficial product innovation utilizing self-growing, fibrous, and natural composite materials with controlled physical properties that can be produced in large quantities. Our product technologies focus on mycelium, the main component of fungi. This emerging biotechnology is used in the creation of carbon neutral products for the building, textile, packaging, and health care industries, as well as in the creation of supplements based on the proven health benefits of mushrooms.
Currently, our research focuses primarily on the significant thermal stability of mycelium materials, a result of mycelium's unique degradation qualities that expand the potential fields of application for mushroom-based products. Mushrooms, Inc.'s long-term goal is to build a strong scalable and widely recognized brand that authentically focuses on sustainable mushroom ingredients and novel functionality stemming from innovative biotech and materials science.
For more information, email info@mushroomsinc.com or visit www.mushroomsinc.com
04/20/2023 Quarterly Report for the period ended March31, 2023
03/06/2023 Attorney Letter with Respect to Current Information - Shell Status Opinion MSRM
03/06/2023 Attorney Letter with Respect to Current Information - MSRM - Current Information Letter
03/06/2023 Annual Report - MSRM 2022 Annual Report
https://www.otcmarkets.com/stock/MSRM/disclosure
Outstanding Shares 37,985,760 04/22/2023
Restricted 33,162,392 04/22/2023
Unrestricted 4,823,368 04/22/2023
update by CEO:
see twitter https://twitter.com/MushroomsInc
MSRM: Update & Acquisitions...Unrestricted shares preserved at 4.8M
Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release | 02/23/2023
ESTERO, FL / ACCESSWIRE / February 23, 2023 / Mushrooms, Inc. (OTC PINK:MSRM) (the "Company") has been quietly making progress within this exciting multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology.
Mushrooms Inc. is developing profitable pathways to sustain the research and development branch which is necessary to achieve viable industrial innovation in this new field.
MSRM is targeting grants specific to their goals, working with pioneers, scientists, and universities, on a global scale to develop scientifically proven products that advance health of body, mind, and environment. They have multiple proposals that they are currently reviewing for their costs to bring to market, timelines, scalability, as well as their positive financial, environmental and health impact. These proposals include a patentable process for the development of mycelium-based building supplies, a patentable process for mushroom related cosmetic and anti-aging skin products, a superfood product not currently seen in the marketplace as well as several remediation projects with new product innovation as an end result. These proposals are being assessed while keeping the progress on an off-shore lab and scientists for an evolved patentable mycelium thread.
GROWTH STRATEGY
In order to offset research costs and time on the industrial development side we are establishing pillars of development outside of the industrial mushroom market through acquisitions and joint ventures. The business model is based on the amazing qualities of mycelium and its networking capabilities as well as its ability to benefit from the network its developing.
CEO Kimberly Carlson shared, "I have been fortunate to connect with amazing pioneers and innovators in differing areas of the Mushroom Market in the US and abroad. Three realities have been consistent with the people behind the businesses and their processes. One is that this business model can bring like-minded companies together in order to benefit and fruit from a shared network under the public umbrella. Secondly, there are natural and substantial cross-points between these companies to mutually benefit from each other while growing as a whole. And the third is that there is a desire for many of these businesses to unite their expertise to others and share from a unified gain. By combining the power of shared ideals and resources through joint ventures, we can move as larger more developed companies do, but without limiting quality and compassion for social and environmental governance."
With a focus on profitability and mutually beneficial cross points, MSRM is assessing partnerships with complimentary businesses which would strategically advance the Company's reach into related markets through joint ventures and M&A activity.
Establishing pillars of development outside of the industrial mushroom market allows for a broad scope of proven profitability and cross-sharing of resources.
We seek to enter partnerships in the Cultivation Market, which includes substrate, spawn production, and fruiting. Cultivation gives life to all market pillars to some degree. It feeds directly into the Mushroom Nutraceutical and Medicinal Psylocibin Market with the addition of extraction, quality testing, product development, and processing. The Medicinal Mushroom Market requires legalization and branches into wellness retreats, treatment certifications and clinics.
MSRM is also evaluating several companies involved in the Myco-Remediation Market which uses fungi to clean oil spills, heavy metals, plastics and other pollutants from soil, water, and the atmosphere. All of these markets relate to the industrial and health innovation that the Company is pursuing in differing aspects and creates a connecting point for acceleration, mutual benefit and market share.
It is the belief of MSRM that connecting these pillars of the mushroom market through joint ventures and acquisitions, while focusing their innovation efforts on the industrial side of the market, will garner cross benefits financially and accelerate timelines during the major research and development phases.
We are simultaneously creating a vertically integrated business model for the businesses involved by aligning strengths between the companies under the umbrella of MSRM.
From an investor perspective, we are creating an avenue for investors to support a larger portion of the mushroom market, establishing a broader financial base of support for and from the networked companies while allowing for a more elastic ability to pivot, expand and connect to new industry pathways as they surface.
Market Opportunity
Mushrooms, Inc. operates in the North American segment of the functional mushroom market in the mycelium material and mushroom supplement product types. According to various industrial research firms, the global functional mushroom market is projected to show a compounded annual growth rate of over 9% for the next five years (Industry Arc and Vantage Market Research). The North American edible mushroom market was worth 11.99 billion in 2023 and is growing at a compounded annual growth rate of 9.48%, forecast to reach 20.91 billion by 2028 (Market Data Forecast). The North American functional mushroom market held 33.8% of the global market in 2020 and is growing at a compounded annual growth rate of 7% (Industry Arc).
Overview
Mushrooms, Inc. is a developing-stage emerging consumer products platform focused on the manufacturing and marketing of highly differentiated mushroom-based materials and functional supplements. The core growth pillars of the Mushrooms, Inc. platform are currently based on developing functional mushroom technologies. As a result of growing consumer demand for innovative, sustainable, and carbon-neutral products, Mushrooms, Inc. plans to grow revenues by penetrating the multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology, as well as expanding our platform to include the creation of supplements based on the proven health benefits of mushrooms.
Mushrooms, Inc. seeks to drive the growth of the bourgeoning functional mushroom industry through product innovation and development. Our current core business activity is environmentally beneficial product innovation utilizing self-growing, fibrous, and natural composite materials with controlled physical properties that can be produced in large quantities. Our product technologies focus on mycelium, the main component of fungi. This emerging biotechnology is used in the creation of carbon neutral products for the building, textile, packaging, and health care industries, as well as in the creation of supplements based on the proven health benefits of mushrooms.
Currently, our research focuses primarily on the significant thermal stability of mycelium materials, a result of mycelium's unique degradation qualities that expand the potential fields of application for mushroom-based products. Mushrooms, Inc.'s long-term goal is to build a strong scalable and widely recognized brand that authentically focuses on sustainable mushroom ingredients and novel functionality stemming from innovative biotech and materials science.
For more information, email info@mushroomsinc.com or visit www.mushroomsinc.com
04/20/2023 Quarterly Report for the period ended March31, 2023
03/06/2023 Attorney Letter with Respect to Current Information - Shell Status Opinion MSRM
03/06/2023 Attorney Letter with Respect to Current Information - MSRM - Current Information Letter
03/06/2023 Annual Report - MSRM 2022 Annual Report
https://www.otcmarkets.com/stock/MSRM/disclosure
Outstanding Shares 37,985,760 04/22/2023
Restricted 33,162,392 04/22/2023
Unrestricted 4,823,368 04/22/2023
update by CEO:
see twitter https://twitter.com/MushroomsInc
MSRM This is totally under the Radar and is REAL. Check the SS , they did file a Patent that is coming up , they do have the product and their Mgt Team actually knows what they are doing.
https://otcmarkets.com/stock/MSRM/security
https://mushroomsinc.com/team-3
https://twitter.com/MushroomsInc
Revenues soon enough will be in the millions.
04/19/2023 Attorney Letter with Respect to Current Information - Attorney Letter
03/15/2023 Annual Report - Annual report
https://www.otcmarkets.com/stock/CRSM/disclosure
CRSM: Float 175M; OS unchanged for 2 years; filings regular (gross provits for the last eight quarters)
Outstanding Shares 595,304,566 04/19/2023
Outstanding Shares 595,304,566 11/12/2021
NAFS CEO & agent name for HRC COFFEE ROASTERS LLC is MARTINEZ, GABRIEL
HRC COFFEE ROASTERS LLC was filed on 01 Mar 2022 as Limited Liability Company type, registered at ONE ALHAMBRA PLAZA PH MIAMI, FL 33134 . It's Document Number is L22000106038, . The state for this company is Florida.There are 2 directors of this company. The company's status is ACTIVE now.
https://www.flcompanyregistry.com/companies/hrc-coffee-roasters-llc/
The director of Havana Roasters Coffee and chairman of NAFS: Yglesias
https://www.otcmarkets.com/stock/NAFS/profile
Outstanding Shares 579,990,956 04/23/2023
Restricted 206,045,491 04/23/2023
Unrestricted 373,945,465 04/23/2023
Getting a few million shares for a low risk/reward ratio. Could easily jump to multiple cents if they follow up on that tweet with news/updated filings
Merger of HRAL with established AI management system; SS preserved with tiny float; little debt
HearAtLast Holdings, Inc OTC: HRAL Signs Agreement to Purchase GetPushMonkey.comPress Release | 04/21/2023
https://www.otcmarkets.com/stock/HRAL/news/HearAtLast-Holdings-Inc-OTC-HRAL-Signs-Agreement-to-Purchase-GetPushMonkeycom?id=397488
GEORGETOWN, ON / ACCESSWIRE / April 21, 2023 / HearAtLast Holdings, Inc, (OTC:HRAL) announces the signing of agreement to purchase GetPushMonkey.com (See https://getpushmonkey.com/) a business development contact management system which utilizes cutting-edge AI data intelligence "web push" that provides businesses with the ability to turn real-time data into actionable insights and personalized customer engagement to generate increased profits.
Web push notifications offer businesses a powerful tool for engaging with their audience and driving conversions, as they can be delivered in real-time and are highly targeted." Overall, I believe, the web push notification market is expected to continue growing in the coming years, as more businesses recognize the value of this powerful marketing channel and invest in innovative solutions to reach and engage with their audience".
"I am excited about the opportunities this merger will bring. We believe that this merger will enable us to expand and better serve our clients and provide them with even greater value". Says CEO Aashish Khandelwal of GetPushMonkey.com. Aashish Khandelwal will be continuing with HRAL following the purchase, heading up the marketing efforts.
Pete Wanner, the CEO of HearAtLast Holdings, Inc, OTC: HRAL states, " We hope to use our network of existing contacts, to drive significant traffic to PushMonkey. We see the partnership with PushMonkey as being a dramatic step forward for both companies"
Market Cap 383,060 04/23/2023
Outstanding Shares 294,661,157 04/23/2023
Restricted 37,574,169 04/23/2023
Unrestricted 257,086,988 04/23/2023
Push Monkey's annual revenue: $1,457,000 Website: https://getpushmonkey.com/
Soc. Media etc:
https://www.linkedin.com/authwall?trk=qf&original_referer=https://www.google.com/&sessionRedirect=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fpushmonkey
https://www.facebook.com/getpushmonkey/
https://www.instagram.com/get_push_monkey/?hl=en
https://www.elegantthemes.com/blog/resources/push-monkey-a-detailed-overview-and-review
Merger of HRAL with established AI management system; SS preserved with tiny float; little debt
HearAtLast Holdings, Inc OTC: HRAL Signs Agreement to Purchase GetPushMonkey.comPress Release | 04/21/2023
https://www.otcmarkets.com/stock/HRAL/news/HearAtLast-Holdings-Inc-OTC-HRAL-Signs-Agreement-to-Purchase-GetPushMonkeycom?id=397488
GEORGETOWN, ON / ACCESSWIRE / April 21, 2023 / HearAtLast Holdings, Inc, (OTC:HRAL) announces the signing of agreement to purchase GetPushMonkey.com (See https://getpushmonkey.com/) a business development contact management system which utilizes cutting-edge AI data intelligence "web push" that provides businesses with the ability to turn real-time data into actionable insights and personalized customer engagement to generate increased profits.
Web push notifications offer businesses a powerful tool for engaging with their audience and driving conversions, as they can be delivered in real-time and are highly targeted." Overall, I believe, the web push notification market is expected to continue growing in the coming years, as more businesses recognize the value of this powerful marketing channel and invest in innovative solutions to reach and engage with their audience".
"I am excited about the opportunities this merger will bring. We believe that this merger will enable us to expand and better serve our clients and provide them with even greater value". Says CEO Aashish Khandelwal of GetPushMonkey.com. Aashish Khandelwal will be continuing with HRAL following the purchase, heading up the marketing efforts.
Pete Wanner, the CEO of HearAtLast Holdings, Inc, OTC: HRAL states, " We hope to use our network of existing contacts, to drive significant traffic to PushMonkey. We see the partnership with PushMonkey as being a dramatic step forward for both companies"
Market Cap 383,060 04/23/2023
Outstanding Shares 294,661,157 04/23/2023
Restricted 37,574,169 04/23/2023
Unrestricted 257,086,988 04/23/2023
Push Monkey's annual revenue: $1,457,000 Website: https://getpushmonkey.com/
Soc. Media etc:
https://www.linkedin.com/authwall?trk=qf&original_referer=https://www.google.com/&sessionRedirect=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fpushmonkey
https://www.facebook.com/getpushmonkey/
https://www.instagram.com/get_push_monkey/?hl=en
https://www.elegantthemes.com/blog/resources/push-monkey-a-detailed-overview-and-review
HRAL merger with established AI management system; SS preserved with tiny float; little debt
HearAtLast Holdings, Inc OTC: HRAL Signs Agreement to Purchase GetPushMonkey.comPress Release | 04/21/2023
https://www.otcmarkets.com/stock/HRAL/news/HearAtLast-Holdings-Inc-OTC-HRAL-Signs-Agreement-to-Purchase-GetPushMonkeycom?id=397488
GEORGETOWN, ON / ACCESSWIRE / April 21, 2023 / HearAtLast Holdings, Inc, (OTC:HRAL) announces the signing of agreement to purchase GetPushMonkey.com (See https://getpushmonkey.com/) a business development contact management system which utilizes cutting-edge AI data intelligence "web push" that provides businesses with the ability to turn real-time data into actionable insights and personalized customer engagement to generate increased profits.
Web push notifications offer businesses a powerful tool for engaging with their audience and driving conversions, as they can be delivered in real-time and are highly targeted." Overall, I believe, the web push notification market is expected to continue growing in the coming years, as more businesses recognize the value of this powerful marketing channel and invest in innovative solutions to reach and engage with their audience".
"I am excited about the opportunities this merger will bring. We believe that this merger will enable us to expand and better serve our clients and provide them with even greater value". Says CEO Aashish Khandelwal of GetPushMonkey.com. Aashish Khandelwal will be continuing with HRAL following the purchase, heading up the marketing efforts.
Pete Wanner, the CEO of HearAtLast Holdings, Inc, OTC: HRAL states, " We hope to use our network of existing contacts, to drive significant traffic to PushMonkey. We see the partnership with PushMonkey as being a dramatic step forward for both companies"
Market Cap 383,060 04/23/2023
Outstanding Shares 294,661,157 04/23/2023
Restricted 37,574,169 04/23/2023
Unrestricted 257,086,988 04/23/2023
Push Monkey's annual revenue: $1,457,000 Website: https://getpushmonkey.com/
Soc. Media etc:
https://www.linkedin.com/authwall?trk=qf&original_referer=https://www.google.com/&sessionRedirect=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fpushmonkey
https://www.facebook.com/getpushmonkey/
https://www.instagram.com/get_push_monkey/?hl=en
https://www.elegantthemes.com/blog/resources/push-monkey-a-detailed-overview-and-review
HRAL merger with established AI management system; SS preserved with tiny float; little debt
HearAtLast Holdings, Inc OTC: HRAL Signs Agreement to Purchase GetPushMonkey.comPress Release | 04/21/2023
https://www.otcmarkets.com/stock/HRAL/news/HearAtLast-Holdings-Inc-OTC-HRAL-Signs-Agreement-to-Purchase-GetPushMonkeycom?id=397488
GEORGETOWN, ON / ACCESSWIRE / April 21, 2023 / HearAtLast Holdings, Inc, (OTC:HRAL) announces the signing of agreement to purchase GetPushMonkey.com (See https://getpushmonkey.com/) a business development contact management system which utilizes cutting-edge AI data intelligence "web push" that provides businesses with the ability to turn real-time data into actionable insights and personalized customer engagement to generate increased profits.
Web push notifications offer businesses a powerful tool for engaging with their audience and driving conversions, as they can be delivered in real-time and are highly targeted." Overall, I believe, the web push notification market is expected to continue growing in the coming years, as more businesses recognize the value of this powerful marketing channel and invest in innovative solutions to reach and engage with their audience".
"I am excited about the opportunities this merger will bring. We believe that this merger will enable us to expand and better serve our clients and provide them with even greater value". Says CEO Aashish Khandelwal of GetPushMonkey.com. Aashish Khandelwal will be continuing with HRAL following the purchase, heading up the marketing efforts.
Pete Wanner, the CEO of HearAtLast Holdings, Inc, OTC: HRAL states, " We hope to use our network of existing contacts, to drive significant traffic to PushMonkey. We see the partnership with PushMonkey as being a dramatic step forward for both companies"
Market Cap 383,060 04/23/2023
Outstanding Shares 294,661,157 04/23/2023
Restricted 37,574,169 04/23/2023
Unrestricted 257,086,988 04/23/2023
Push Monkey's annual revenue: $1,457,000 Website: https://getpushmonkey.com/
Soc. Media etc:
https://www.linkedin.com/authwall?trk=qf&original_referer=https://www.google.com/&sessionRedirect=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fpushmonkey
https://www.facebook.com/getpushmonkey/
https://www.instagram.com/get_push_monkey/?hl=en
https://www.elegantthemes.com/blog/resources/push-monkey-a-detailed-overview-and-review
Confirmed; Today same SS as for months:
Outstanding Shares 294,661,157 04/22/2023
Restricted 37,574,169 04/22/2023
Unrestricted 257,086,988 04/22/2023